100
Participants
Start Date
July 24, 2013
Primary Completion Date
April 24, 2015
Study Completion Date
June 11, 2018
Regorafenib (Stivarga, BAY73- 4506)
160 mg regorafenib per oral every day for 3 weeks of every 4 week cycle (i.e., 3 weeks on, 1 week off)
Gaziantep
Istanbul
Istanbul
Izmir
Ankara
Ankara
Antalya
Bursa
Kayseri
Samsun
Balcali/Adana
Lead Sponsor
Bayer
INDUSTRY